【以“防病治病”为目的的新型中医药研发与中医药创新】。

Q3 Pharmacology, Toxicology and Pharmaceutics
Rui-Ting Lyu, Yan-Ling Ai, Zhong-Qi Yang, Ting Wang, Jian-Yuan Tang
{"title":"【以“防病治病”为目的的新型中医药研发与中医药创新】。","authors":"Rui-Ting Lyu, Yan-Ling Ai, Zhong-Qi Yang, Ting Wang, Jian-Yuan Tang","doi":"10.19540/j.cnki.cjcmm.20250310.603","DOIUrl":null,"url":null,"abstract":"<p><p>In the development of traditional Chinese medicine(TCM), the concept of &quot;preventive treatment of disease&quot; has a long history and plays a crucial role in bridging the past and the future. With the continuous growth of public health needs and the ongoing transformation of the registration management of TCM, its position in the research and development of new drugs has become increasingly significant. As one of the important sources of new drug innovation, the new TCM for &quot;preventive treatment of diseases&quot; represents a new thinking proposed based on the current routine registration and research and development. The research and development of TCM for &quot;preventive treatment of diseases&quot; mainly cover four stages: prevention(before the onset of disease), early intervention(when the disease is about to occur), interruption and reversal(when the disease has already occurred), and prevention of recurrence after recovery(after the disease). This study aims to comprehensively analyze the positioning, key points, and difficulties in the research and development of TCM for &quot;preventive treatment of diseases&quot; and explore effective paths to promote the innovative development of TCM through relevant cases. The research and development of new TCM for &quot;preventive treatment of disease&quot; require researchers to seize the opportunities for innovation before the start of the research and development, accurately grasp the key issues at different stages, and pay attention to the full lifecycle evaluation of the drugs. Meanwhile, in the design of the research plan, the optimal effectiveness evaluation indicators should be explored; key and difficult areas such as chronic diseases and rare diseases should be taken seriously, and the limitations of new drug development only based on the diagnosed diseases should be broken, so as to cater to more patients. In addition, through relevant representative cases in China and abroad, the unique advantages of TCM for &quot;preventive treatment of diseases&quot; should be fully leveraged. By learning from the past, all aspects of key points in the evaluation of new drug research and development should be strengthened. Finally, this study proposed that TCM for &quot;preventive treatment of diseases&quot; can employ novel methods and advanced technologies such as new biomarkers and innovative clinical design protocols, as well as new perspectives on disease research and health management. This can provide new paths for the innovation of TCM and public health management.</p>","PeriodicalId":52437,"journal":{"name":"Zhongguo Zhongyao Zazhi","volume":"50 13","pages":"3589-3595"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Research and development of new traditional Chinese medicine (TCM) for \\\"preventive treatment of diseases\\\" and innovation of TCM].\",\"authors\":\"Rui-Ting Lyu, Yan-Ling Ai, Zhong-Qi Yang, Ting Wang, Jian-Yuan Tang\",\"doi\":\"10.19540/j.cnki.cjcmm.20250310.603\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In the development of traditional Chinese medicine(TCM), the concept of &quot;preventive treatment of disease&quot; has a long history and plays a crucial role in bridging the past and the future. With the continuous growth of public health needs and the ongoing transformation of the registration management of TCM, its position in the research and development of new drugs has become increasingly significant. As one of the important sources of new drug innovation, the new TCM for &quot;preventive treatment of diseases&quot; represents a new thinking proposed based on the current routine registration and research and development. The research and development of TCM for &quot;preventive treatment of diseases&quot; mainly cover four stages: prevention(before the onset of disease), early intervention(when the disease is about to occur), interruption and reversal(when the disease has already occurred), and prevention of recurrence after recovery(after the disease). This study aims to comprehensively analyze the positioning, key points, and difficulties in the research and development of TCM for &quot;preventive treatment of diseases&quot; and explore effective paths to promote the innovative development of TCM through relevant cases. The research and development of new TCM for &quot;preventive treatment of disease&quot; require researchers to seize the opportunities for innovation before the start of the research and development, accurately grasp the key issues at different stages, and pay attention to the full lifecycle evaluation of the drugs. Meanwhile, in the design of the research plan, the optimal effectiveness evaluation indicators should be explored; key and difficult areas such as chronic diseases and rare diseases should be taken seriously, and the limitations of new drug development only based on the diagnosed diseases should be broken, so as to cater to more patients. In addition, through relevant representative cases in China and abroad, the unique advantages of TCM for &quot;preventive treatment of diseases&quot; should be fully leveraged. By learning from the past, all aspects of key points in the evaluation of new drug research and development should be strengthened. Finally, this study proposed that TCM for &quot;preventive treatment of diseases&quot; can employ novel methods and advanced technologies such as new biomarkers and innovative clinical design protocols, as well as new perspectives on disease research and health management. This can provide new paths for the innovation of TCM and public health management.</p>\",\"PeriodicalId\":52437,\"journal\":{\"name\":\"Zhongguo Zhongyao Zazhi\",\"volume\":\"50 13\",\"pages\":\"3589-3595\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zhongguo Zhongyao Zazhi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19540/j.cnki.cjcmm.20250310.603\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhongguo Zhongyao Zazhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19540/j.cnki.cjcmm.20250310.603","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

在中医的发展过程中,“防病治病”的理念源远流长,在承前接后中起着至关重要的作用。随着公共卫生需求的不断增长和中药注册管理体制的不断变革,中药在新药研发中的地位日益显著。“预防疾病”新中药作为新药创新的重要来源之一,代表了在当前常规注册和研发的基础上提出的一种新思维。中医“防病治病”的研究与发展主要包括四个阶段:预防(发病前)、早期干预(即将发病时)、中断与逆转(已发病时)、康复后预防复发(病后)。本研究旨在通过相关案例,全面分析中医药“防病治病”研发的定位、重点和难点,探索促进中医药创新发展的有效路径。“防病治病”新中药的研发,要求科研人员在研发开始前抓住创新机遇,准确把握不同阶段的关键问题,注重对药物的全生命周期评价。同时,在研究方案的设计中,探索最优的有效性评价指标;要重视慢性病、罕见病等重点难点领域,打破仅根据确诊疾病开发新药的局限,满足更多患者的需求。此外,通过国内外相关代表性案例,充分发挥中医药“防病治病”的独特优势。总结过去的经验教训,加强新药研发评价的各方面要点。最后,本研究提出中医药“预防疾病”可以采用新的方法和先进的技术,如新的生物标志物和创新的临床设计方案,以及疾病研究和健康管理的新视角。这可以为中医创新和公共卫生管理提供新的路径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Research and development of new traditional Chinese medicine (TCM) for "preventive treatment of diseases" and innovation of TCM].

In the development of traditional Chinese medicine(TCM), the concept of "preventive treatment of disease" has a long history and plays a crucial role in bridging the past and the future. With the continuous growth of public health needs and the ongoing transformation of the registration management of TCM, its position in the research and development of new drugs has become increasingly significant. As one of the important sources of new drug innovation, the new TCM for "preventive treatment of diseases" represents a new thinking proposed based on the current routine registration and research and development. The research and development of TCM for "preventive treatment of diseases" mainly cover four stages: prevention(before the onset of disease), early intervention(when the disease is about to occur), interruption and reversal(when the disease has already occurred), and prevention of recurrence after recovery(after the disease). This study aims to comprehensively analyze the positioning, key points, and difficulties in the research and development of TCM for "preventive treatment of diseases" and explore effective paths to promote the innovative development of TCM through relevant cases. The research and development of new TCM for "preventive treatment of disease" require researchers to seize the opportunities for innovation before the start of the research and development, accurately grasp the key issues at different stages, and pay attention to the full lifecycle evaluation of the drugs. Meanwhile, in the design of the research plan, the optimal effectiveness evaluation indicators should be explored; key and difficult areas such as chronic diseases and rare diseases should be taken seriously, and the limitations of new drug development only based on the diagnosed diseases should be broken, so as to cater to more patients. In addition, through relevant representative cases in China and abroad, the unique advantages of TCM for "preventive treatment of diseases" should be fully leveraged. By learning from the past, all aspects of key points in the evaluation of new drug research and development should be strengthened. Finally, this study proposed that TCM for "preventive treatment of diseases" can employ novel methods and advanced technologies such as new biomarkers and innovative clinical design protocols, as well as new perspectives on disease research and health management. This can provide new paths for the innovation of TCM and public health management.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Zhongguo Zhongyao Zazhi
Zhongguo Zhongyao Zazhi Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.50
自引率
0.00%
发文量
581
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信